Watson news

Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents

Watson Pharmaceuticals Inc. WKSI Shelf Rated Prelim. BBB

Zikkir World - 18 minutes ago
NEW YORK, Aug. 18, 2009–Standard & Poor's Ratings Services said today that it assigned its preliminary 'BBB-' rating to senior unsecured securities and preliminary 'BB' rating to preferred stock ...

Watson Fentanyl Patch Problems Lead to Equipment Adjustments

AboutLawsuits.com - 51 minutes ago
Following a fentanyl patch recall issued in early August due to manufacturing defects that could allow medication to leak directly onto the skin and potentially cause a fatal overdose, Watson ...

Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R)...

Watson to Present at the Bank of America Merrill Lynch Global Healthcare Conference

Generic Morning After Pill Gets Final Go-Ahead From Food and Drug Administration

LifeNews.com - 1 hour ago
by Steven Ertelt Washington, DC (LifeNews.com) -- The Food and Drug Administration has given the final go-ahead for Watson Pharmaceuticals Inc. to sell its generic version of the morning after ...

Watson Pharmaceuticals granted FDA approval for generic PLAN B for over-the-counter use

Trading Markets - 3 hours ago
Aug 31, 2009 (M2 EQUITYBITES via COMTEX) -- WPI | Quote | Chart | News | PowerRating -- Pharmaceutical company Watson Pharmaceuticals Inc (NYSE:WPI) reported on Friday that its subsidiary Watson ...

US HOT STOCKS: Pacer Intl, Tessera Active In Late Trading

Wall Street Journal - 54 minutes ago
US stocks were mixed Friday as the Dow Jones Industrial Average fell 36 points to 9544 and the S&P 500 lost 2.1 points to 1029. But the Nasdaq Composite inched up 1 point to 2029. Among the ...

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use

SYS-CON Media - 3 minutes ago
MORRISTOWN, NJ, Aug. 28 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories ...